Understanding the Fundraising Environment for Biotech Companies
October 15, 2024
Venetian Room
The latest HSBC Venture Healthcare report shows increased levels of investment in 2024 with Seed and Series A total investment doubling and investment in preclinical deals already surpassing 2023. The HSBC Innovation team will provide a summary presentation on these promising signals followed by a panel discussion where investors and biotech executives will provide strategies for companies to access capital and continue advancing their therapies to the next phase of development.
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}